310 related articles for article (PubMed ID: 15694133)
1. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.
Patel K; Amthor H
Neuromuscul Disord; 2005 Feb; 15(2):117-26. PubMed ID: 15694133
[TBL] [Abstract][Full Text] [Related]
2. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.
Wagner KR; McPherron AC; Winik N; Lee SJ
Ann Neurol; 2002 Dec; 52(6):832-6. PubMed ID: 12447939
[TBL] [Abstract][Full Text] [Related]
3. Functional improvement of dystrophic muscle by myostatin blockade.
Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
[TBL] [Abstract][Full Text] [Related]
4. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.
Matsakas A; Diel P
Int J Sports Med; 2005 Mar; 26(2):83-9. PubMed ID: 15726494
[TBL] [Abstract][Full Text] [Related]
5. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
[TBL] [Abstract][Full Text] [Related]
6. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.
Bartoli M; Poupiot J; Vulin A; Fougerousse F; Arandel L; Daniele N; Roudaut C; Noulet F; Garcia L; Danos O; Richard I
Gene Ther; 2007 May; 14(9):733-40. PubMed ID: 17330087
[TBL] [Abstract][Full Text] [Related]
7. Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C.
Bogdanovich S; McNally EM; Khurana TS
Muscle Nerve; 2008 Mar; 37(3):308-16. PubMed ID: 18041051
[TBL] [Abstract][Full Text] [Related]
8. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
9. Targeting myostatin for therapies against muscle-wasting disorders.
Tsuchida K
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
[TBL] [Abstract][Full Text] [Related]
10. Myostatin expression in muscular dystrophies and mitochondrial encephalomyopathies.
Castro-Gago M; Blanco-Barca MO; Eiris-Puñal J; Carneiro I; Arce VM; Devesa J
Pediatr Neurol; 2006 Apr; 34(4):281-4. PubMed ID: 16638502
[TBL] [Abstract][Full Text] [Related]
11. The possible role of myostatin in skeletal muscle atrophy and cachexia.
Jespersen J; Kjaer M; Schjerling P
Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
[TBL] [Abstract][Full Text] [Related]
12. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
[TBL] [Abstract][Full Text] [Related]
13. Alterations of temporalis muscle contractile force and histological content from the myostatin and Mdx deficient mouse.
Byron CD; Hamrick MW; Wingard CJ
Arch Oral Biol; 2006 May; 51(5):396-405. PubMed ID: 16263075
[TBL] [Abstract][Full Text] [Related]
14. Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases.
Tobin JF; Celeste AJ
Curr Opin Pharmacol; 2005 Jun; 5(3):328-32. PubMed ID: 15907921
[TBL] [Abstract][Full Text] [Related]
15. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
[TBL] [Abstract][Full Text] [Related]
16. [Altered expression of myostatin gene in the progressive muscular dystrophy patients].
Zhang Y; Chen Y; Chen JW; Zhu DH
Yi Chuan Xue Bao; 2005 Aug; 32(8):779-83. PubMed ID: 16231730
[TBL] [Abstract][Full Text] [Related]
17. Prolonged absence of myostatin reduces sarcopenia.
Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
[TBL] [Abstract][Full Text] [Related]
18. Mighty is a novel promyogenic factor in skeletal myogenesis.
Marshall A; Salerno MS; Thomas M; Davies T; Berry C; Dyer K; Bracegirdle J; Watson T; Dziadek M; Kambadur R; Bower R; Sharma M
Exp Cell Res; 2008 Mar; 314(5):1013-29. PubMed ID: 18255059
[TBL] [Abstract][Full Text] [Related]
19. Regulation of muscle mass by myostatin.
Lee SJ
Annu Rev Cell Dev Biol; 2004; 20():61-86. PubMed ID: 15473835
[TBL] [Abstract][Full Text] [Related]
20. Marked reduction of focal adhesion kinase, serum response factor and myocyte enhancer factor 2C, but increase in RhoA and myostatin in the hindlimb dy mouse muscles.
Sakuma K; Nakao R; Inashima S; Hirata M; Kubo T; Yasuhara M
Acta Neuropathol; 2004 Sep; 108(3):241-9. PubMed ID: 15221330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
